227 related articles for article (PubMed ID: 30217807)
1. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
Robinson-Cohen C; Bartz TM; Lai D; Ikizler TA; Peacock M; Imel EA; Michos ED; Foroud TM; Akesson K; Taylor KD; Malmgren L; Matsushita K; Nethander M; Eriksson J; Ohlsson C; Mellström D; Wolf M; Ljunggren O; McGuigan F; Rotter JI; Karlsson M; Econs MJ; Ix JH; Lutsey PL; Psaty BM; de Boer IH; Kestenbaum BR
J Am Soc Nephrol; 2018 Oct; 29(10):2583-2592. PubMed ID: 30217807
[TBL] [Abstract][Full Text] [Related]
2. Common genetic variants associate with serum phosphorus concentration.
Kestenbaum B; Glazer NL; Köttgen A; Felix JF; Hwang SJ; Liu Y; Lohman K; Kritchevsky SB; Hausman DB; Petersen AK; Gieger C; Ried JS; Meitinger T; Strom TM; Wichmann HE; Campbell H; Hayward C; Rudan I; de Boer IH; Psaty BM; Rice KM; Chen YD; Li M; Arking DE; Boerwinkle E; Coresh J; Yang Q; Levy D; van Rooij FJ; Dehghan A; Rivadeneira F; Uitterlinden AG; Hofman A; van Duijn CM; Shlipak MG; Kao WH; Witteman JC; Siscovick DS; Fox CS
J Am Soc Nephrol; 2010 Jul; 21(7):1223-32. PubMed ID: 20558539
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study for circulating fibroblast growth factor 21 and 23.
Chuang GT; Liu PH; Chyan TW; Huang CH; Huang YY; Lin CH; Lin JW; Hsu CN; Tsai RY; Hsieh ML; Lee HL; Yang WS; Robinson-Cohen C; Hsiung CN; Shen CY; Chang YC
Sci Rep; 2020 Sep; 10(1):14578. PubMed ID: 32884031
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants Associated with Circulating Parathyroid Hormone.
Robinson-Cohen C; Lutsey PL; Kleber ME; Nielson CM; Mitchell BD; Bis JC; Eny KM; Portas L; Eriksson J; Lorentzon M; Koller DL; Milaneschi Y; Teumer A; Pilz S; Nethander M; Selvin E; Tang W; Weng LC; Wong HS; Lai D; Peacock M; Hannemann A; Völker U; Homuth G; Nauk M; Murgia F; Pattee JW; Orwoll E; Zmuda JM; Riancho JA; Wolf M; Williams F; Penninx B; Econs MJ; Ryan KA; Ohlsson C; Paterson AD; Psaty BM; Siscovick DS; Rotter JI; Pirastu M; Streeten E; März W; Fox C; Coresh J; Wallaschofski H; Pankow JS; de Boer IH; Kestenbaum B
J Am Soc Nephrol; 2017 May; 28(5):1553-1565. PubMed ID: 27927781
[TBL] [Abstract][Full Text] [Related]
5. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
[TBL] [Abstract][Full Text] [Related]
7. RGS14 regulates PTH- and FGF23-sensitive NPT2A-mediated renal phosphate uptake via binding to the NHERF1 scaffolding protein.
Friedman PA; Sneddon WB; Mamonova T; Montanez-Miranda C; Ramineni S; Harbin NH; Squires KE; Gefter JV; Magyar CE; Emlet DR; Hepler JR
J Biol Chem; 2022 May; 298(5):101836. PubMed ID: 35307350
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.
Meyer MB; Pike JW
J Steroid Biochem Mol Biol; 2020 Feb; 196():105500. PubMed ID: 31629064
[TBL] [Abstract][Full Text] [Related]
9. Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Gattineni J; Alphonse P; Zhang Q; Mathews N; Bates CM; Baum M
Am J Physiol Renal Physiol; 2014 Feb; 306(3):F351-8. PubMed ID: 24259513
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
[TBL] [Abstract][Full Text] [Related]
11. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
12. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
Quarles LD
Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
14. Short-term fasting of mice elevates circulating fibroblast growth factor 23 (FGF23).
Feger M; Alber J; Strotmann J; Grund A; Leifheit-Nestler M; Haffner D; Föller M
Acta Physiol (Oxf); 2023 Dec; 239(4):e14049. PubMed ID: 37746883
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
Latic N; Erben RG
Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
[TBL] [Abstract][Full Text] [Related]
16. Genomic mechanisms controlling renal vitamin D metabolism.
Meyer MB; Pike JW
J Steroid Biochem Mol Biol; 2023 Apr; 228():106252. PubMed ID: 36657729
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
[TBL] [Abstract][Full Text] [Related]
18. Role of the vitamin D receptor in FGF23 action on phosphate metabolism.
Inoue Y; Segawa H; Kaneko I; Yamanaka S; Kusano K; Kawakami E; Furutani J; Ito M; Kuwahata M; Saito H; Fukushima N; Kato S; Kanayama HO; Miyamoto K
Biochem J; 2005 Aug; 390(Pt 1):325-31. PubMed ID: 15885032
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
